arm II

DIETARY_SUPPLEMENT2 trials

Sponsors

Cooperative Study Group A for Hematology, Bioagile Therapeutics Pvt. Ltd.

Conditions

ACUTE MYELOGENOUS LEUKEMIAOverweight (BMI > 25)

Phase 3

High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML

CompletedNCT00474006

Cooperative Study Group A for HematologyACUTE MYELOGENOUS LEUKEMIA

Start: 2001-08-31End: 2010-04-30Updated: 2011-06-10

Unknown Phase

To Evaluate Efficacy and Safety of Proprietary Healthy Diet Combinations for Weight Management in Overweight Volunteers

CompletedNCT07452757

Bioagile Therapeutics Pvt. Ltd.Overweight (BMI > 25)

Start: 2023-11-15End: 2024-05-13Updated: 2026-03-12

Related Papers

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia.

2011-08-09108 citations